GDF15 and left ventricular hypertrophy: In the randomized controlled clinical studies conducted by Xue et al. in 2012 and Kou et al. in 2016, it was found that levels of MIC-1/GDF-15 were significantly higher in hypertensive patients with left ventricular hypertrophy when compared with the control population [34,35].